Compare SCSC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCSC | INMD |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 869.5M | 805.0M |
| IPO Year | 1997 | 2018 |
| Metric | SCSC | INMD |
|---|---|---|
| Price | $44.18 | $13.21 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $64.50 | $15.33 |
| AVG Volume (30 Days) | 316.4K | ★ 558.3K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.33 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $3,846,260,000.00 | N/A |
| Revenue This Year | $12.92 | N/A |
| Revenue Next Year | $5.96 | $2.02 |
| P/E Ratio | $106.36 | ★ $10.11 |
| Revenue Growth | ★ 7.79 | N/A |
| 52 Week Low | $33.76 | $12.72 |
| 52 Week High | $66.78 | $16.67 |
| Indicator | SCSC | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 25.12 | 40.49 |
| Support Level | $34.23 | $12.72 |
| Resistance Level | $46.64 | $13.98 |
| Average True Range (ATR) | 2.78 | 0.45 |
| MACD | -1.57 | -0.01 |
| Stochastic Oscillator | 18.03 | 8.84 |
ScanSource Inc is a technology distributor uniquely positioned to address complex, converging technologies and to accelerate growth for channel sales partners across hardware, SaaS, connectivity, and cloud. The Company provides technology solutions and services from suppliers of mobility and barcode, POS, payment terminals, physical security, networking, communications, connectivity, and cloud services to channel sales partners located mainly in the United States and Brazil. It has two reportable segments based on the sales model: Specialty Technology Solutions, which generates maximum revenue and includes hardware, SaaS, and subscription services through a wholesale/resale sales model, and Intelisys & Advisory. Geographically, it derives the majority of its revenue from the United States.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.